Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Inner Mongolia University of Science and Technology | OTHER |
| Inner Mongolia Hulunboir hospital | UNKNOWN |
| Inner Mongolia People's Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Under the premise of double-blind and non-interference clinical treatment, to evaluate the clinical efficacy and safety of probiotic Lactobacillus Zhang combined with routine treatment for gout hyperuricemia.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group | Experimental |
| |
| Control group | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Probiotics | Dietary Supplement | Patients will be randomly assigned to the routine treatment + placebo group and probiotics + routine treatment group according to 1:2 ratio. |
|
| Measure | Description | Time Frame |
|---|---|---|
| serum uric acid level | The serum uric acid level was standard-reaching rate at the end of 24 weeks(Percentage of patients whose serum uric acid level has decreased to less than 360umol / L ) | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| serum uric acid level at the 4、8、12、24 weeks | the serum uric acid level and the percentage of patients with < 360umol / L at the end of 4, 8, 12 and 24 weeks after treatment | 4、8、12、24 weeks |
| serum uric acid decreased from baseline |
Not provided
Inclusion Criteria:
Subjects are eligible for inclusion in this study only if they meet all of the following criteria
Exclusion Criteria:
If the subjects meet any of the following criteria, they will not be selected :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Inner Mongolia Medical College Affiliated Hospital | Recruiting | Hohhot | Inner Mongolia | 010000 | China |
Not provided
| ID | Term |
|---|---|
| D006073 | Gout |
| D033461 | Hyperuricemia |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D000070657 | Crystal Arthropathies |
Not provided
Not provided
| ID | Term |
|---|---|
| D019936 | Probiotics |
| ID | Term |
|---|---|
| D019587 | Dietary Supplements |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
Not provided
Not provided
| Inner Mongolia Ordos Central Hospital |
| UNKNOWN |
| Inner Mongolia Baogang Hospital | OTHER |
| Inner Mongolia Medical College | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
| uric-acid-lowering drug | Drug | Patients will be randomly assigned to the routine treatment + placebo group and probiotics + routine treatment group according to 1:2 ratio. |
|
At the end of 4, 8, 12 and 24 weeks after treatment, the serum uric acid level decreased from baseline
| 4、8、12、24 weeks |
| Acute attack of gout | Number of acute gout attacks during 24 weeks of treatment | 24 week |
| D012216 |
| Rheumatic Diseases |
| D011686 | Purine-Pyrimidine Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D019602 |
| Food and Beverages |